Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel and Cyclophosphamide in Breast Cancer
NCT01540110Phase 2Completed
- Sponsor
- National Cancer Centre Singapore
- Start
- Aug 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cyclophosphamide in breast cancer, sponsored by National Cancer Centre Singapore. Started Aug 2010; status: completed.
02
Drugs
docetaxelcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01540110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540110.